ConductScience.org, home

Trial · NCT05401565

Results by group46

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScorePlaceboBaseline35.5Standard Deviation 9.3Score on a Scale
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScoreBalovaptanBaseline33.8Standard Deviation 7.8Score on a Scale
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScorePlaceboWeek 6-6.8Standard Deviation 11.2Score on a Scale
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScoreBalovaptanWeek 6-10.3Standard Deviation 9.2Score on a Scale
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScorePlaceboWeek 12-15.6Standard Deviation 10.6Score on a Scale
Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity ScoreBalovaptanWeek 12-17.2Standard Deviation 10.7Score on a Scale
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboBaseline Very mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanBaseline Very mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboBaseline Mild1Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanBaseline Mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboBaseline Moderate3Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanBaseline Moderate8Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboBaseline Severe11Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanBaseline Severe5Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboBaseline Very severe0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanBaseline Very severe0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboWeek 6 Very mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanWeek 6 Very mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScorePlaceboWeek 6 Mild0Participants
Symptom Severity as Measured by Clinician-Global Impression of Severity (CGI-S) Scale ScoreBalovaptanWeek 6 Mild4Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05401565/results